A brief period in which British family doctors were offered a financial inducement to treat diabetic patients more intensively could be coming to an end.
 

Seven years ago, after strong media, clinical and patient pressure, the Government negotiated a “risk-sharing” deal over access to drugs to treat multiple sclerosis.

The NHS Information Centre has issued some “experimental statistics” covering the take-up of medicines approved by the National Institute for health and Clinical Excellence (NICE).